| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/30/2000 | US6069150 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents |
| 05/30/2000 | US6069147 Adjustment of metabolism |
| 05/30/2000 | US6069143 Anticoagulants |
| 05/30/2000 | US6069140 Pharmaceutical compositions comprising texaphyrins |
| 05/30/2000 | US6069133 Targeted delivery of genes encoding interferon |
| 05/30/2000 | US6069129 Elastin derived composition and method of using same |
| 05/30/2000 | US6069006 Connective tissue growth factor (CTGF) regulatory nucleic acid sequences |
| 05/30/2000 | US6068984 Separating hb15 prositive cells from population of unrelated cells by reacting antibody that specifically binds the extracellular, transmembrane or cytoplasmic domain of the glycoprotein, then isolating cells |
| 05/30/2000 | US6068850 A stable aqueous formulation of a peptide related compound comprising atleast one peptide compoun and water, wherein the formulation is stable at 37 degree c. atleast 2 months, useful in an implantable drug delivery device |
| 05/30/2000 | US6068845 Inhibitory activity on the abnormal production of extracellular matrices in dermal fibroblasts activated with tranforming growth factor beta by administering the plant extract of a plant belonging to the genus sophora |
| 05/30/2000 | CA2206104C Adamantyl substituted oxindoles as pharmaceuticals agents |
| 05/30/2000 | CA2159326C Method for treating amyloidosis |
| 05/25/2000 | WO2000029620A1 Methods of facilitating vascular growth |
| 05/25/2000 | WO2000029602A1 Transfection of male germ cells for generation of selectable transgenic stem cells |
| 05/25/2000 | WO2000029601A1 A method for depopulating of vertebrate testis and for generation of transgenic species |
| 05/25/2000 | WO2000029590A1 Method for identifying inhibitors of ipc synthase |
| 05/25/2000 | WO2000029583A2 Immunoglobulin superfamily proteins |
| 05/25/2000 | WO2000029581A1 Human tslp dna and polypeptides |
| 05/25/2000 | WO2000029570A1 Novel protein and utilization thereof |
| 05/25/2000 | WO2000029569A1 Methods of diagnosing or treating neurological diseases |
| 05/25/2000 | WO2000029553A1 Bioengineered tissue constructs and methods for producing and using them |
| 05/25/2000 | WO2000029447A1 Rhamm antagonist antibodies |
| 05/25/2000 | WO2000029438A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 05/25/2000 | WO2000029435A1 12 human secreted proteins |
| 05/25/2000 | WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | WO2000029397A1 New piperazine and piperidine compounds |
| 05/25/2000 | WO2000029384A1 2-phenylbenzimidazoles and 2-phenylindoles, and production and use thereof |
| 05/25/2000 | WO2000029377A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 05/25/2000 | WO2000029371A1 Excitatory amino acid receptor modulators |
| 05/25/2000 | WO2000029023A1 Cox-2 inhibitors in combination with nmda-blockers for treating pain |
| 05/25/2000 | WO2000029020A1 Anti-icam-r antibody-induced apoptosis |
| 05/25/2000 | WO2000029015A2 INFLUENCING OF ANGIGENESIS USING CD66a |
| 05/25/2000 | WO2000029014A1 Method of treating heparin-induced thrombocytopenia |
| 05/25/2000 | WO2000029011A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/25/2000 | WO2000029005A1 Method for producing an agent for treating non-cancerous pathologies of the organism |
| 05/25/2000 | WO2000028983A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 05/25/2000 | WO2000028980A2 Combination of duloxetine with non-steroidal antiinflammatory drug for treating pain |
| 05/25/2000 | WO2000028979A1 Dry powder for inhalation |
| 05/25/2000 | WO2000028942A1 Process for the manufacture of liquid filled capsules |
| 05/25/2000 | WO2000016755A3 Antiviral combinations of lamivudine and adefovir |
| 05/25/2000 | WO2000015209A3 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
| 05/25/2000 | WO2000012111A3 Selective treatment of endothelial somatostatin receptors |
| 05/25/2000 | WO2000012049A3 A method for the treatment of staphylococcal disease |
| 05/25/2000 | WO2000007545A8 Apoptosis proteins |
| 05/25/2000 | WO2000001410A9 Methods of inhibiting proliferative diseases by inhibiting tgf-beta mediated angiogenesis |
| 05/25/2000 | WO1999026644A9 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
| 05/25/2000 | DE19955793A1 CCR-3-Rezeptor-Antagonisten CCR-3 receptor antagonists |
| 05/25/2000 | DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases |
| 05/25/2000 | CA2351585A1 Influencing of angigenesis using cd66a |
| 05/25/2000 | CA2351522A1 Egf-like nucleic acids and polypeptides and uses thereof |
| 05/25/2000 | CA2351224A1 Cox-2 inhibitors in combination with nmda-blockers for treating pain |
| 05/25/2000 | CA2351067A1 Method of treating heparin-induced thrombocytopenia |
| 05/25/2000 | CA2350914A1 Treatment of tumors by administration of growth hormone releasing compounds and their antagonists |
| 05/25/2000 | CA2350722A1 4-aroyl-piperidin-ccr-3 receptor antagonists iii |
| 05/25/2000 | CA2350532A1 Excitatory amino acid receptor modulators |
| 05/25/2000 | CA2350531A1 Method for treating pain |
| 05/25/2000 | CA2349869A1 Novel protein and utilization thereof |
| 05/25/2000 | CA2349762A1 Human tslp dna and polypeptides |
| 05/25/2000 | CA2349581A1 Anti-icam-r antibody-induced apoptosis |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/25/2000 | CA2348744A1 Method for producing an agent for treating non-cancerous pathologies of the organism |
| 05/25/2000 | CA2348459A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | CA2340468A1 Methods of facilitating vascular growth |
| 05/24/2000 | EP1002862A1 Methods of diagnosing or treating neurological diseases |
| 05/24/2000 | EP1002802A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1002799A1 Optically pure androgen mediator |
| 05/24/2000 | EP1002797A1 4,5-DIHYDRO- 1H]-BENZ g]INDAZOLE-3-CARBOXYLIC ACID DERIVATIVES |
| 05/24/2000 | EP1002794A1 4-[(Aryl)(aryloxy)methyl]piperidine derivatives and their use as serotonin and/or noradrenaline reuptake inhibitors |
| 05/24/2000 | EP1002547A1 Hydrosoluble hedgehog protein in ionic complex and pharmaceutical use thereof |
| 05/24/2000 | EP1002545A1 Suppressive agent against expression of cell adhesion molecules |
| 05/24/2000 | EP1002543A1 Pharmaceutical compositions for the therapy of glioma or prostate cell proliferative disorders containing cyclic rgd compounds |
| 05/24/2000 | EP1002542A1 Method for treating the endotoxic shock in mammals |
| 05/24/2000 | EP1002535A1 New use of glutamate antagonists for the treatment of cancer |
| 05/24/2000 | EP1002534A1 Bis-Staurosporine and K-252a derivatives |
| 05/24/2000 | EP1002531A1 A water-miscible composition of non-steroidal antiinflammatory drugs |
| 05/24/2000 | EP1002132A1 90 human secreted proteins |
| 05/24/2000 | EP1002091A1 Nucleic acid sequence and method for selectively expressing a protein in a target cell or tissue |
| 05/24/2000 | EP1002081A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 05/24/2000 | EP1002074A1 Calcium-binding phosphoprotein |
| 05/24/2000 | EP1002073A2 Cell activation process and reagents therefor |
| 05/24/2000 | EP1002072A1 Human semaphorin e and polynucleotides encoding it |
| 05/24/2000 | EP1002070A1 Human atp-binding cassette transport protein |
| 05/24/2000 | EP1002069A1 Peptides containing the motif igd and their use as cell migration modulators |
| 05/24/2000 | EP1001985A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 05/24/2000 | EP1001984A1 NOVEL ESTROGEN RECEPTOR $g(b) AND ISOFORMS |
| 05/24/2000 | EP1001983A1 NOVEL ESTROGEN $g(b) RECEPTOR AND ISOFORMS |
| 05/24/2000 | EP1001979A1 Cyclic azapeptides with angiogenic effect |
| 05/24/2000 | EP1001978A1 Angiotensin derivatives |
| 05/24/2000 | EP1001976A2 Peptides having potassium channel opener activity |
| 05/24/2000 | EP1001975A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001973A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001972A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001970A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1001956A1 New 2,3-benzodiazepine derivatives |
| 05/24/2000 | EP1001946A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES |
| 05/24/2000 | EP1001945A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES |
| 05/24/2000 | EP1001941A1 Fused heterocyclic compounds and their use as kynurenine-3-hydroxylase inhibitors |
| 05/24/2000 | EP1001940A1 Condensed pyrazole compounds |
| 05/24/2000 | EP1001935A1 Indole derivatives as mcp-1 receptor antagonists |
| 05/24/2000 | EP1001934A1 Indole compounds as cox-2 inhibitors |